Related News
JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal Disorders
Business Wire 2024-07-18, 19:52Related News
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
Business Wire2024-02-29, 13:03
JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 31st ...
Business Wire2024-10-16, 17:12
JCR Pharmaceuticals Presents Preclinical Gene Therapy Research at the European Society of Gene and Cell ...
Business Wire2024-10-23, 13:03
JCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II Study of JR-171 in ...
Business Wire2023-09-29, 12:49
M6P Therapeutics Presents Promising Preclinical Data In Lysosomal Storage Disorders At The 19th Annual WORLDSymposium™ 2023
Nasdaq Globe Newswire2023-02-21, 13:28
JCR Pharmaceuticals Initiates First Dosing in Phase I Clinical Trial of JR-441 for Mucopolysaccharidosis Type IIIA
Business Wire2024-10-31, 17:05